Cellebrite lists 93,989 shares under Rule 144

Cellebrite DI Ltd. submitted a Rule 144 notice relating to Ordinary shares, par value NIS 0.00001, tied to vested Restricted Share Units under an issuer S-8 registered plan.

Rhea-AI Filing Summary

Cellebrite DI Ltd. submitted a Rule 144 notice relating to Ordinary shares, par value NIS 0.00001, tied to vested Restricted Share Units under an issuer S-8 registered plan.

The filing lists 93,989 shares and references broker Morgan Stanley Smith Barney LLC; transaction dates shown include 07/07/2026 and 07/08/2026.

Key Figures

Shares listed: 93,989 shares Numeric entry: 1,470,928 Numeric entry: 249,439,817 +3 more

6 metrics

Shares listed 93,989 shares referenced in filing tied to vested RSUs

Numeric entry 1,470,928 number present in excerpt (role not specified)

Numeric entry 249,439,817 number present in excerpt (role not specified)

Par value NIS 0.00001 Ordinary shares par value

Broker listed Morgan Stanley Smith Barney LLC broker associated with the sale

Dates referenced 07/07/2026; 07/08/2026 transaction/reporting dates shown

Key Terms

Restricted Share Units, S-8, Rule 144

3 terms

Restricted Share Units financial

"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

S-8 regulatory

"Issuer S-8 Registered Plan"

A Form S-8 is a U.S. regulatory filing that gives a public company permission to register shares it will issue to employees, directors or consultants under stock-based compensation plans. Think of it as a formal “permission slip” that lets a company grant or sell stock for pay or bonuses; investors watch it because those shares can increase the number of shares outstanding and affect ownership, earnings per share and dilution.

Rule 144 regulatory

"Securities To Be Sold ... Restricted Share Units Vested Under an Issuer S-8 Registered Plan"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CLBT Form 144 filing report?

The filing reports a Rule 144 resale notice for Ordinary shares tied to vested Restricted Share Units under an issuer S-8 registered plan. It lists 93,989 shares and names Morgan Stanley Smith Barney LLC as the broker.

How many shares are referenced in the CLBT filing?

The filing references 93,989 Ordinary shares. The document also contains numeric entries 1,470,928 and 249,439,817 but their roles are not clarified in the provided excerpt.

What dates appear in the Cellebrite Form 144 excerpt?

The excerpt shows transaction or reporting dates of 07/07/2026 and 07/08/2026. The context ties the shares to vested RSUs and the S-8 plan on those dates.

Who is the listed broker in the filing for CLBT?

The broker named is Morgan Stanley Smith Barney LLC, with an address at 1 New York Plaza, 8th Floor, New York. The filing lists the broker in connection with the shares to be sold.

Are the shares in the filing part of a compensation plan?

Yes. The shares are described as resulting from Restricted Share Units vested under an issuer S-8 registered plan, indicating they arise from compensation awards that have vested.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 07:17 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001706672
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cellebrite DI Ltd.
SEC File Number	001-40772
Address of Issuer	94 SHLOMO SHMELZER ROAD PETAH TIKVA ISRAEL 4970602
Phone	972-73-394-8000
Name of Person for Whose Account the Securities are To Be Sold	David Barter
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary shares, par value NIS 0.00001	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	93989	1470928	249439817	07/08/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary shares, par value NIS 0.00001	07/07/2026	Restricted Share Units Vested Under an Issuer S-8 Registered Plan	CELLEBRITE DI LTD.			93989	07/07/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The reporting person intends to sell securities reported herein on 07/08/2026 pursuant to a mandatory, non-discretionary, sell-to-cover arrangement for the purposes of satisfying income tax liabilities incurred upon vesting of restricted share unit awards only.
Date of Notice	07/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ David Barter
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)